SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " biomedical " 100 found 🔀 AI-powered Shuffle
Sign in to save shuffle history.
Eric Topol
The famed cardiologist discusses how AI has transformed biomedical science
New framework renders AI trustworthy for cancer subtyping
The framework, reported in Nature Biomedical Engineering, is broadly adaptable as a wrapper for digital pathology AI systems.
Advanced Health Research on Station Using Augmented, Virtual Reality Tools
Biomedical tests using augmented and virtual reality tools to advance space health dominated the research schedule aboard the International Space Station on Wednesday. The Expedition 74 crew is also turning its attention to a spacewalk at the end of the month following the departure of a U.S. cargo spacecraft.
UWA awarded National Institutes of Health funding for research equipment
A grant from the National Institutes of Health is making way for new biomedical research opportunities for students and faculty at the University of West Alabama. The funding is UWA’s first National Institutes of Health (NIH) award, marking a significant milestone in the institution’s research growth.
UC Davis Undergraduates Take Top Prize at Big Bang! Business Competition
UC Davis Mike and Renée Child Institute for Innovation and Entrepreneurship awarded nearly $100,000 at the 26th annual Big Bang! Business Competition, with the top prize going to First Bite, a biomedical engineering student team developing a safer device to secure breathing tubes for infants.
Peroxisome structure can help protect insulin and maintain beta cell health
Researchers at LSU's Pennington Biomedical Research Center have identified a previously underappreciated role for tiny structures inside cells called peroxisomes in protecting insulin and maintaining ...
Biomedical Sciences Graduate Health Professions Exploration Fair, Oct. 6
Meet with admission representatives from over 30 graduate health programs to learn more about career opportunities, education requirements, the admission process and more.
Democrats Condemn NIH-DOD Research Agreement
The Defense Department could tap up to $2 billion in federal research dollars designated for biomedical research, under an agreement signed with the National Institutes of Health.
NextGen internship program offers a whirlwind tour of genetics
From working in a research lab to participating in hands-on group activities, high school students get an inside look at biomedical science during a five-week summer internship with the Department of Human Genetics.
Verily Health to Integrate PacBio HiFi Sequencing With Data Platform
The multi-year collaboration will link PacBio sequencing workflows to Verily Pre to support biomedical research and AI model training.
UT San Antonio academic health center ranked among nation’s best for entrepreneurial readiness
UT Health San Antonio, The University of Texas at San Antonio’s academic health center, has been recognized as one of the nation’s top 10 institutions for entrepreneurial readiness, ranking No. 7 in the inaugural Cure Innovation Index for how effectively it helps researchers translate scientific discovery into real-world impact through biomedical innovation and commercialization. […]
Transcat expands biomedical business with $12.8M acquisition
Transcat expands its biomedical calibration business with a $12.8 million acquisition of Southeastern Biomedical Associates in North Carolina, extending its reach in the Southeast.
Upcoming Science Cafe
BAR HARBOR—Join us for a fascinating Science Cafe with environmental toxicologist Nishad Jayasundara, Ph.D., as he explores how everyday contaminants and other stressors such as heat exposure may be quietly influencing kidney health. Chronic kidney disease (CKD) affects nearly 1 in 7 adults in the United States—and more than 840 million people worldwide. While factors like diet and genetics are well known, scientists are increasingly uncovering another important piece of the puzzle: environmental exposure. Drawing on his team’s research, Dr. Jayasundara, Maine INBRE alum as a College of the Atlantic undergraduate student and past MDI Bio Lab Visiting Scientist, will share how early-life exposure to environmental toxins can disrupt kidney development, and may affect kidney structure and function in adults. Blending cutting-edge research with real-world relevance, this Science Cafe will shed light on an important and often overlooked contributor to human health—and what it could mean for communities around the world. Monday, August 17, 2026 at 5 p.m.Hybrid event at Maren Auditorium and via Zoom Register Now What Are Science Cafes? MDI Bio Lab’s Science Cafes provide an informal introduction to ground-breaking biomedical research by its scientists, scholars from near and far and from local experts in other fields as well. Each Cafe lasts about one hour; the floor is open for questions and discussion. It can get lively and it’s always engaging. MDI Science Cafes are open to the public and free of charge. For more information, or to watch past events, visit our website. The MDI Science Cafe Series is brought to you by Cross Insurance. Subscribe Share Leave a comment
European Union innovation needs regulatory science excellence centres
Nature Biomedical Engineering - Fit-for-purpose regulation of medical devices and medical artificial intelligence in Europe needs Centres of Excellence in Regulatory Science and Innovation,...
Diabetes researchers ejected from conference after criticizing White House
The scientists, including the editor of a leading journal, were handing out copies of an editorial criticizing the Trump administration’s handling of biomedical research.
New framework aims to improve reliability of tear-based health sensors
Dr. Yangzhi Zhu of the Terasaki Institute for Biomedical Innovation (TIBI), with collaborators at UC San Diego and USC, published a Nature Sensors perspective on what it will take to turn tear-based wearable sensors into reliable, long-term health-tracking tools.
When machines misread science: creating guardrails for human and AI interpretation of biomedical research
npj Digital Medicine - Artificial intelligence is increasingly acting as a first interpreter of biomedical research, shaping how evidence is applied to patient care. Simultaneously, science is...
Making Our Own Luck
We are cross-posting a piece that former NIH official Kris Willis wrote for Macroscience. Kris is now the President and Founder of the Woodley Park Institute, for which I’m a board member. Picking winners or hedging bets? Federal science agencies have long wrestled with the question of how to ensure their billions of dollars of grants and contracts result in maximum benefits for Americans. On the surface, it might seem that a goal-oriented, interventionist style of management would be the best policy: prioritize our most pressing problems and distribute funding accordingly.This top-down strategy creates a unique hazard, though: bad choices can send resources in the wrong direction, resulting in slow progress that impedes the delivery of tangible benefits to citizens. Moreover, if decision makers pursue an applied advance when the underlying scientific principles remain poorly understood, they risk costly failures and a loss of support for the research enterprise at large. Examples include Nixon’s 1971 War on Cancer, undertaken on the premise that a cure could be achieved in less than a decade, the drive to build an operational commercial fusion plant by the mid-1990s, and the National Plan to Address Alzheimer’s Disease, which failed to produce the effective treatments and prevention strategies promised by 2025. The contrasting laissez-faire approach is to hedge your bets. If the path to an advance is impossible to predict, then the wisest choice might be to distribute funding to as widely as possible. The main risk of this strategy is that spreading funding thinly may limit the resources available to the most promising research, resulting in the same negative outcomes as the interventionist approach: limited support for the most promising topics, slow progress, and delayed returns. In reality, at science agencies like the National Science Foundation and National Institutes of Health, program managers navigate between these two extremes, setting some funds aside to target high-priority areas and using the rest to cover the widest possible range of meritorious proposals. This middle path seems like the most rational way to proceed, but it still requires making choices. How much should be set aside for high priority topics? What should those topics be? How should we define merit? Expert opinion can provide a helpful guide, but leading experts can have remarkably different opinions about what matters and what should be prioritized. Moreover, experts and administrators alike can be risk averse, giving an edge to high-profile, well-established concepts. What’s really needed is a data-driven framework to help guide decision-making, one that doesn’t simply repackage prestige or incumbency. Recognizing breakthroughs years in advance Many breakthroughs fail to attract funding or recognition at the earliest stages of development. Katalin Karikó, for example, spent years struggling to win grants for work on mRNA that would eventually win her and Drew Weissman a Nobel Prize. Similar stories can be told about Jim Allison’s groundbreaking studies leading to the development of cancer immunotherapy, Stan Pruisner’s demonstration that prions can self-replicate without DNA, or Robin Warren and Barry Marshall’s proof that Helicobacter pylori, not stress, causes ulcers. Yet at some point, the scientific community recognizes and responds to transformative breakthroughs like these. How does that change happen? And what if science funders could identify the areas that are on the cusp of a breakthrough? Those questions led my collaborators and me to study how scientists responded to past breakthroughs. Based on patterns in that data, we developed a means of predicting future breakthroughs, using biomedicine as a proof of concept. It’s worth taking a moment to describe how our approach works. Briefly, our prediction process begins by grouping the 18 million or so peer-reviewed papers in PubMed, the authoritative database of biomedical research, into roughly 50,000 unique topics. A small subset of these topics are so widely acclaimed as breakthroughs that they have been recognized with a major prize like a Nobel or a Lasker Award. We theorized that studying the development of these outliers over time, especially before they gained acclaim, was the key to identifying future instances of them. After defining topics, we chose 21 representative breakthroughs and asked what they looked like before they won prestigious prizes. To answer that question, we re-ran our topic-mapping algorithm repeatedly, winding back the clock one year each time, stringing together the years to follow the progress of each field as it grew and advanced. We found that in each case, the years leading up to a discovery followed a pattern: a burst of papers on a new, rapidly evolving topic, many of which quickly became influential. These characteristics—the percent of papers that are new, the percentage of papers that are brought in from other topics, and the influence of each individual paper—can all be measured separately for any given topic. Together, they act as a predictive signal that is detectable an average of five years before a transformative discovery is made, and up to thirty years before the discovery receives a major prize. Scanning the current research landscape for topics that display this signal allows us to predict what work will likely produce a future breakthrough. Each year we analyzed includes four or five signals, a number that appears to have remained constant across a twenty year time frame. In their classic work on the sociology of science, Bruno Latour and Steve Woolgar established that the desire to participate in a major discovery is an important motivator for scientists as they consider whether they should take up (or abandon) a research problem. Although further work is needed, the simplest explanation for our results is that this behavior is widespread enough to detect at scale. A foundational advance, or something like it, draws the attention of scientists and causes them to change the direction of their research. They vote with their feet, staking their own reputation and careers by publishing on and citing the new idea. That upswell of interest is the foundation of our breakthrough signal. What kind of research does our model identify as a breakthrough? After building a model based on the patterns in our 21 preselected breakthroughs, we tested it by identifying all early signals of discovery from 1994 through 1997. Of the 18 signals we found in that time period, 17 can be traced forward in time to a breakthrough. Examples include super-resolution fluorescence microscopy (see the image above), the directed evolution of proteins and enzymes (Chemistry Nobel, 2018), and sequencing the human genome (National Medal of Science, 2008). The discovery of the role of leptin signaling in obesity is a particularly interesting case study. Around 1950, scientists noticed the existence of a type of lab mouse that suffered from a unique inherited form of obesity. When given the freedom to choose their own diet, these mice ate more than normal and preferred food that was high in fat. Researchers had few clues as to why the animals overate; early experiments pointed to the existence of a soluble ob factor found circulating in the bloodstream that regulated appetite, but its identity was unknown. In 1994, Jeffrey Friedman and colleagues identified and sequenced the ob gene, noting that the protein it encoded appeared to fit the profile of a circulating factor. A year later, a trio of high-profile publications demonstrated that ob was a hormone that regulated body weight and fat deposition by regulating appetite. One of these was co-authored by Friedman, who christened it leptin from the ancient Greek word for thin. Using our model, the data from 1996 make it clear this advance would become a breakthrough. Scientists had flocked to study the biology of the new hormone, generating the flurry of new papers and citations required to produce a signal. One of these demonstrated that serum leptin concentrations reflected the amount of adipose tissue in the human body, providing clinical validation of the earlier mouse studies. Before the identification of leptin, scientists were unable to point to a specific molecule that controlled appetite and adiposity, so that it was impossible to rule out non-physiological causes of obesity; its characterization fundamentally changed our concept of weight gain. In 2010, Friedman and fellow pioneer Douglas Coleman were awarded a Lasker for the discovery. Our work also identifies breakthroughs in clinical practice and behavioral and social sciences, even though these areas are less likely to draw the attention of major prize committees. One example that falls into this category is the introduction of endovascular aneurysm repair, a minimally invasive surgical procedure for the treatment of abdominal aortic aneurysm, a leading cause of death among Americans over the age of 65. Relative to the previous standard of care, it reduces in-hospital mortality by almost four-fold. In 2017, Timothy Chuter received the American College of Surgeons’ prestigious Jacobsen Innovation award for his multiple refinements to the technique. Another under-recognized breakthrough identified by our model is the development of standardized survey instruments to assess the quality of life for HIV+ patients. The antiretroviral cocktails introduced in the mid-1990s reduced AIDS mortality, but treatment came with serious side effects. The new evaluations showed that patients whose disease progressed had worse physical functioning than Americans with other chronic diseases, while those who were asymptomatic maintained a health-related quality of life on par with the overall US population. This evidence made it possible for patients and activists to argue that even in the absence of a total cure, and in spite of the side effects, alleviation of symptoms was a worthwhile priority for clinicians. My colleagues and I have failed to identify any significant recognition for the physicians and health policy experts who pioneered this advance, although in 2016, researchers called for the World Health Organization to set targets for good health-related quality of life as part of its framework to end the AIDS pandemic. From forecasting to funding How should science funders use our predictions? Any serious discussion of what we should do with this new capability needs to begin with an understanding of its limitations. We can’t (and shouldn’t) invest all of our resources in the small number of topics predicted to produce breakthroughs. Innovative new fields are born from existing ones; they rarely arise de novo. If funders don’t maintain a diverse portfolio, the breakthroughs of tomorrow will have no antecedents. Think of this as eating the seed corn, or killing the goose that lays the golden egg. There are also multiple goals of funding beyond basic scientific discovery, including translating discoveries into clinical practice, developing new technologies, supporting economic development, and training new scientists. The investments needed to accomplish these goals are likely different from those required to support emerging breakthroughs. Finally, we must be aware that we may not capture every instance of a breakthrough. The concept is fuzzy, and not every significant discovery is recognized with a major award. Further, breakthroughs are rare, meaning that our dataset is, by necessity, small. This makes formal estimates of accuracy challenging. Although our overall success rate appears to be high, any one signal may turn out to be a false positive. We found one apparent example: the development of the third generation COX-2 inhibitors, Vioxx and Celebrex, which were much celebrated in the early 2000s as effective but non-addictive pain relievers, meets all the algorithmic criteria of a breakthrough. Five years after it received FDA approval, researchers demonstrated that Vioxx was associated with serious cardiovascular complications, and the manufacturer voluntarily pulled the drug from the market. Celebrex remains available, although like other NSAIDs, it carries an FDA warning for increased cardiovascular risk. Decision makers who were overly focused on the breakthrough potential of this research might have wasted substantial resources nurturing an area that ultimately proved to be a failure—but so would those who relied on expert opinion at the time. That said, the potential benefits of funding the next mRNA vaccine or cancer immunotherapy years earlier than we might have are large. When we can’t assume the outcome of an action, it’s worth conducting an experiment. Can targeted support for areas that are poised to produce a breakthrough increase the return on scientific investment without cannibalizing future advances? With the necessary administrative infrastructure in place, conducting this experiment would be straightforward. First, identify all the breakthrough signals between 2018 and 2023, select half at random, and commit to a decade of investment. For biomedicine, a six year window should yield about 30 topics with the potential to produce a breakthrough. Providing strong support to half of these might be accomplished for $300 million a year. That’s roughly half of the recent annual budget of the NIH Common Fund or around 20% of the fiscal year 2025 budget for ARPA-H. After five years, then again at ten, compare to see which group — the one that was actively managed, or the control — produced more breakthroughs, and on what timescale. Although we used biomedicine as an example, the same experiment could just as well be run for physics, materials science, or any other discipline. Any attempt to undertake such an experiment should keep three points top of mind. First, we can predict the topic of future breakthroughs, but the people and vision for how to move the work forward are still important. In practice, this means success requires active program managers with the expertise to develop the science and the authority to do so, including by recruiting investigators. Second, we would be wise to learn from the failures of past attempts to fund transformative research. High among these are funding modestly repackaged work, confusing the genuinely novel with the merely unfamiliar, and relying too much on incumbent investigators. All of these risks can be mitigated by thoroughly and intelligently integrating high quality data into portfolio management. Finally, we need to have patience. Even with strong funding support, producing a breakthrough takes time. If supporting breakthroughs is the best way to nurture the birth of new fields, we also need to accurately describe and properly manage the other two stages, so that we invest wisely throughout the productive lifetime of ideas and divest once they reach the point of diminishing returns. We would benefit from more study of all of these phases, especially the transition from one to another. More research could answer questions like: When does a breakthrough become an established field? How do the availability of funding, the size and characteristics of the available workforce, and the accumulation of evidence that disagrees with prevailing models affect a field’s decline? Exactly how do old ideas give birth to new ones, and can we speed up the process? The more we understand about the dynamics of scientific progress, the better we can maximize the odds that our curiosity leads to results. I’d call that finding a way to make our own luck.
President’s message: Progress and opportunity for science and medicine
his is an extraordinary moment in time for the biomedical sciences. Seven decades ago, the discovery of the structure of DNA sparked a revolution in understanding life. In the decades since, the knowledge of fundamental biology we have accumulated has led to innovative treatments for many difficult-to-treat diseases, and many more are now within reach....
How brain cells restore healthy growth and connections after a disease-causing genetic deletion
Scientists at Virginia Tech's Fralin Biomedical Research Institute at VTC have discovered how an experimental therapy can help brain cells overcome the effects of a disease-causing genetic deletion. Instead ...
Mount Sinai and Hasso Plattner Institute Launch International Graduate Student Exchange Program to Advance Digital Health and AI Innovation
The Icahn School of Medicine at Mount Sinai and the Hasso Plattner Institute for Digital Engineering (HPI) are expanding their academic collaboration in digital health through the launch of a new graduate student exchange program offered through Mount Sinai’s Graduate School of Biomedical Sciences.
MSU College of Letters and Science Distinguished Professor to talk about pursuing passions and excellence in Oct. 8 lecture
Brian Bothner will reflect on a career advancing biomedical research, mentoring students and expanding scientific opportunities across Montana in a free, public lecture at the Museum of the Rockies on Oct. 8.
New course examines engineering challenges, opportunities in women’s health
A new Duffield Engineering biomedical engineering course will challenge students to investigate real-world failures in women’s health technologies and identify opportunities for better design.
23 student researchers receive 2026 NSF fellowships - College of Arts and Sciences
The National Science Foundation awarded work in STEM-related fields such as artificial intelligence, biomedical engineering and marine ecology.
Renowned Mote Marine Science and Education Center Opens New Aquarium in Sarasota Using Penetron Technology
Situated on a 12-acre site within Nathan Benderson Park in Sarasota, the Mote SEA campus features state-of-the-art STEM teaching labs for biomedical science, microbiology and immunology; marine and coastal ecology; and ocean engineering, AI technology, robotics, and sensor development. These labs provide hands-on learning opportunities for more than 70,000 K–12 students each year from Sarasota and Manatee County schools, as well as schools in nearby counties.
Flagship Pioneering and Lean Business Services Company Announce Collaboration to Advance Healthcare Innovation and AI-Enabled Biomedical Research in Saudi Arabia
/PRNewswire/ -- Flagship Pioneering, the scientific innovation company behind Moderna, Generate Biomedicines, and more than 100 other life sciences ventures,...
Anthropic’s Claude Science app is coming for Kendall Square
Few places on the planet have more at stake in AI’s transformation and disruption of life sciences than the Massachusetts biomedical ecosystem.
RIX Industries Partners with Build Health International to Bring Medical Oxygen Compressor Training to Africa
New program at Kigali College of Rwanda Polytechnic puts RIX factory-level compressor training within reach of hospital biomedical technicians across the continentBENICIA, Calif., Sept. 15, 2026 (GLOBE NEWSWIRE) -- RIX Industries, a recognized leader in advanced gas compression, gas generation, and precision-engineered technologies, today announced a formal training partnership with Build Health International (BHI), a nonprofit organization specializing in designing and building healthcare infra
Renowned Life Science Leader Dr. Gino Martini Joins KIFFIK Biomedical as Chief Scientific Officer
Dr. Martini brings extensive industry, government, and academic expertise to KIFFIK Biomedical, strengthening translational science capabilities as the company advances its K-EXP™ platform and expands access to interstitial fluid (ISF)
CBIH Announces Expanded Research Strategy at the Intersection of Endocannabinoid Science and Biological Medicine
Houston, Texas--(Newsfile Corp. - October 19, 2026) - Cannabis Bioscience International Holdings, Inc. (OTC Pink: CBIH), a public company trading on the OTC Markets under the ticker symbol CBIH, announced an expansion of its scientific research strategy focused on the intersection of endocannabinoid biology, precision medicine, and the development of intellectual property with potential biomedical applications."We are witnessing a new era in the history of medicine: an era in which human biology
Curiosity-driven research explained: Basic science lays the foundation for life-saving discoveries - Morgridge Institute for Research
When scientists ask fundamental questions about life, biomedical breakthroughs follow — often at a distance. Why should we embrace the long, unpredictable path from curiosity to cure?
Ukrainian health care teams visit to learn best practices and take their knowledge home
Ten Ukrainian health care professionals visited the Vanderbilt Transplant Center, Vanderbilt-Ingram Cancer Center and the Department of Biomedical Informatics
The 2026 Science Division Distinguished Alumni Award recipients
Gregory Reyes (Kresge ’76, biology), Larry de Ghetaldi (Merrill ’76, biology and chemistry), and Nicholas Suntzeff (Ph.D. ’80, astronomy) are recognized for careers of exceptional distinction in biomedical research, healthcare policy, and observational cosmology.
A milestone year for Morgridge Summer Science Camp
On July 31, the 20th annual Morgridge Summer Science Camp said good-bye to its final group of campers. Over the course of three one-week sessions, 75 students along with their teachers, from 13 districts across the state, envisioned their futures in the biomedical sciences at the Discovery Building and UW–Madison’s campus.
Cancer’s Andreana Holowatyj honored by Chamber of Commerce
Holowatyj leads a renowned biomedical research program committed to tackling the rising tide of early-onset cancers among adults under age 50.
23 student researchers receive 2026 NSF fellowships
The National Science Foundation awarded work in STEM-related fields such as artificial intelligence, biomedical engineering and marine ecology.
Texas Tech University Health Sciences Center Appoints New Graduate School of Biomedical Sciences Dean and Vice Dean
TTUHSC has named Lance R. McMahon, Ph.D., as the new Graduate School of Biomedical Sciences dean and Kendra P. Rumbaugh, Ph.D., as vice dean.
Why are biomedical scientists being vilified?
Protect those scientists who provide the underlying research that can continue furthering progress toward lifesaving preventions and treatments
Trump’s $6 Billion Science Plan Targets AI, Moon and Mars
Trump unveils over $6 billion in science initiatives supporting AI, quantum computing, nuclear-powered Moon and Mars projects, and biomedical research.
Influential Women Showcases Madison Tyler: Making Complex Biomedical Science Clear, Accurate, And Accessible
Founder of MAT Communications Brings Research Experience and Scientific Writing Expertise to Science Communications and Medical Affairs Salem, Connecticut –
New schizophrenia treatments, AI in mental health among topics at inaugural symposium in Roanoke
The two-day gathering on precision therapeutics will be held at the Fralin Biomedical Research Institute at VTC.
UT San Antonio prepares biomedical researchers for entrepreneurial innovation
UT San Antonio is preparing biomedical researchers to think beyond scientific discovery, equipping them to consider how promising research can move from the laboratory toward real-world impact.
Global Health Watch: LEN Access Pathways, NIAID Reorganization, Global Fund Report, NIH Lawsuit
This week’s issue covers developments shaping access to HIV prevention and the future of US biomedical research, including new pathways to accelerate access to lenacapavir for HIV PrEP, calls for greater transparency around a proposed NIAID restructuring, and a new lawsuit challenging NIH’s screening of research grants. With today as the final day to comment […]
Pennington expert talks about the impact of sleep on mental health
An expert with the Pennington Biomedical Research Center is talking about the importance of sleep during Mental Health Awareness Month.
Meet Biomni
In creating a comprehensive, AI-enabled research agent for the biomedical sciences, Stanford researchers hope to speed innovation by eliminating the tedium of scientific legwork.
3 newsy must-reads on AI in healthcare (plus 3 bonus picks)
1.) Some clinical AI has a fuzzy ROI. That doesn’t mean it shouldn’t be reimbursed. 2.) What makes biomedical research different from other sectors where AI has been quickly adopted? 3.) Unmoved by enthusiasm, health execs are making AI decisions around organizational priorities.
U.S., U.K. health care systems share a fatal flaw
“The default to biomedical responses means that clinics and hospitals are increasingly absorbing the costs of social problems,” writes Kyle Vanelli.
Biomedical Sciences Graduate Health Professions Exploration Fair, Oct. 6
Meet with admission representatives from over 30 graduate health programs to learn more about career opportunities, education requirements, the admission process and more.
Paul Harris elected to National Academy of Medicine
Paul Harris, PhD, Professor of Biomedical Informatics at Vanderbilt Health, has been elected to the National Academy of Medicine (NAM).
How UT San Antonio is helping close the gap in the Texas healthcare workforce
More than 1,100 students annually across medicine, nursing, dentistry, allied health, biomedical sciences, and public health graduate.
Under Trump, NIH funding disruptions have evolved. Here's what the numbers show
Stories of science funding being cut, labs shutting down and scientists losing jobs have flooded the media under Trump's administration. These six graphics show how those changes have affected U.S. biomedical research.
NEWS: Biomedical Studies, NSF-Funded Science, Student-Led Projects, and More on NASA’s SpaceX CRS-35
ISS National Lab-sponsored research aims to advance regenerative medicine, improve understanding of natural hazards, and inspire the next generation of scientists and explorers
50 Years of Engineering Better Health - USC Viterbi
BME 50 -The Alfred E. Mann Department of Biomedical Engineering at USC Viterbi and Keck celebrated 50 years of excellence and innovation with a two-day gathering
Dolly’s generosity to Vanderbilt Health highlighted; reading test results before your doctor has a chance; staying healthy this fall; plus other stories with Vanderbilt Health sources
Dolly Parton’s generosity to Vanderbilt Health was mentioned in many of her obituaries. A sampling: The New York Times, the BBC, NPR, NBC News, The Guardian, and Scripps News. Vanderbilt Health News posted a tribute to her, as well, and Mark Denison, MD, Professor Emeritus of Pediatrics and former director of the Division of Pediatric Infectious Diseases, spoke to NewsNation for a story about her impact on his research. Everyday Health interviewed Trent Rosenbloom, MD, MPH, Professor of Biomedical Informatics, for a story about a new JAMA study that found two-thirds of patients read test results before connecting with a doctor. Comprehension of test results varied: 6.6 percent said they had a poor understanding, 26.8 percent understood the results fairly well, 31.7 percent understood them well, and 34.9 percent understood the results very well. William Schaffner, MD, Professor of Preventive Medicine, was quoted by several news outlets about public health issues, including: Healthline (cyclosporiasis cases now in 47 states); “The Naked Scientists” podcast (salmonella outbreak sickens hundreds); Medscape (the lighter-than-usual just-completed Australian flu season); and People (how to stay healthy this fall). Scripps News interviewed Jessica Young, MD, Associate Professor of Clinical Obstetrics and Gynecology, about Vanderbilt researchers launching a study to determine if GLP-1 drugs can help people with opioid use disorder. WSMV Channel 4 News reporter Diana Rocco interviewed Kashish Goel, MBBS, Associate Professor of Medicine and Director of Transcatheter Heart Valve Interventions, for a story about patient Dixie Watt and her minimally invasive valve replacement with the M3 device, the first Food and Drug Administration-approved transseptal transcatheter mitral valve replacement. Fogarty International Center writer/editor Susan Scutti interviewed John Koethe, MD, Associate Professor of Medicine, Division of Infectious Disease, for a profile article for their newsletter, Global Health Matters. The article presents him as an example of a Fogarty Fellow success story and focus on his past and present research, including the HIV/AIDS research he conducted for his Fogarty project at the Centre for Infectious Diseases Research in Zambia in 2008 and 2009.
Engineering’s Shuo Li selected for Crain’s Cleveland Business’ 2026 Notable Leaders in Architecture, Engineering and Construction | CWRU Newsroom
Shuo Li, PhD, the Leonard Case, Jr. Professorship in Engineering at the Case Western Reserve University Department of Biomedical Engineering, was sele...
Sally Kornbluth
The university president and biomedical scientist talks about the hope and doubt in U.S. science today
Why General AI Coding Assistants Fall Short in Science
Generic AI coding assistants struggle with scientific workflows. Rolv v3 adds reproducibility, biomedical intelligence, HPC execution, and visual DAGs.
AI is everywhere. Should you use it for health advice?
The following expert commentary can be used by journalists and media organizations in their own publications and news coverage. Please attribute all quotes to Xiaoqian Jiang, PhD, chair of the Department of Health Data Science and Artificial Intelligence at McWilliams School of Biomedical Informatics at UTHealth Houston.
Texas Tech University Health Sciences Center Appoints New Graduate School of Biomedical Sciences Dean and Vice Dean
TTUHSC has named Lance R. McMahon, Ph.D., as the new Graduate School of Biomedical Sciences dean and Kendra P. Rumbaugh, Ph.D., as vice dean.
Master of Science in Biomedical Sciences awards top students - News
The Jerry M. Wallace School of Osteopathic Medicine recognized Masters of Science in Biomedical Sciences graduates who received academic awards… More on this post
ADHD UK Cannot Hide the Flawed Science Behind the Diagnosis and Its Treatment
The extensive critique of the biomedical account of ADHD and its treatment with stimulant medication has persisted for decades.
Agentic AI in biomedical research: What is it and can it expedite science?
Researchers are venturing into a new area of collaboration that relies on agentic AI, co-scientists that can act independently and help humans ideate, hypothesize and speed up scientific exploration.
Blue Turf Thinkers: Biomedical Research Institute investigates harmful diseases
At each Boise State home football game, the “Blue Turf Thinkers” series honors outstanding groups...
New Biomedical Sciences Undergraduate Research Program Offers Valuable Lab Experience
The Undergraduate Program for Research Immersion & Scholarly Mentorship will enable undergraduate students in the Institute for Biomedical Sciences to gain meaningful research experiences in the institute’s labs.
USPTO Expands Category A Patent Bar Admission Criteria to Include Biomedical Science Degree
The USPTO published a Federal Register Notice Tuesday announcing administrative updates to the General Requirements Bulletin (GRB).
Molecular imaging pioneer Eva Nogales awarded the 2026 Vanderbilt Prize in Biomedical Science
The Vanderbilt Prize in Biomedical Science recognizes scientists who have a stellar record of research accomplishments.
Richard E. Carson, Ph.D., receives SNMMI 2026 Paul C. Aebersold Award for Outstanding Achievement in Basic Nuclear Medicine Science
Richard E. Carson, PhD, has been named the 2026 recipient of the prestigious Paul C. Aebersold Award. Carson is professor of Biomedical Engineering and of Radiology and Biomedical Imaging at Yale University in New Haven, Connecticut, as well as emeritus director of the Yale PET Center. The award was announced by the Society of Nuclear Medicine and Molecular Imaging (SNMMI) during its 2026 Annual Meeting.
Biomedical Studies, NSF-Funded Science, Student-Led Projects, and More on NASA’s SpaceX CRS-35
More than two dozen ISS National Lab-sponsored investigations launched on SpaceX CRS-35, advancing regenerative medicine, NSF-funded science, and education.
BEACON: How Benchmarking Combats the Reproducibility Crisis in Modern Science
A new initiative called BEACON aims to advance scientific reproducibility by uniting siloed benchmarking efforts across biomedical research.
Master’s Program Revamped to Address Informatics Needs
The Master of Science in Biomedical Informatics program — previously known as the Master of Science in Health and Biomedical Informatics — will launch in the fall offering two tracks: one in bioinformatics and another in health informatics.
Chairman Griffith Delivers Opening Statement at Subcommittee on Health Hearing on Maintaining U.S. Leadership in Biomedical Innovation
The Committee on Energy and Commerce is the oldest standing legislative committee in the U.S. House of Representatives and is vested with the broadest jurisdiction of any congressional authorizing committee.
Purdue students get firsthand look at health-care innovation
A new Parkview-Purdue immersion program gives students hands-on exposure to hospital technology, patient care and innovation.
Using AI for medical advice; pelvic floor exercises; the hidden dangers of burning incense; plus other stories with Vanderbilt Health sources
Colin Walsh, MD,Associate Professor of Biomedical Informatics, was on WTVF News Channel 5‘s “Morningline” show in an interview about whether or not it is safe to use AI for medical advice. Time magazine reporter Stacey Colino interviewed Elisabeth Sebesta, MD, Assistant Professor of Urology, for a story about pelvic floor exercises for issues including menopause, erectile dysfunction and urinary incontinence in men. “Each Breath,” published by the American Lung Association, quoted Brian Christman, MD, Adjunct Professor of Medicine, for a story about the hidden dangers of burning incense. William Schaffner, MD, Professor of Preventive Medicine, was quoted by several news outlets about public health issues, including: Healthline (low vaccination rates lead to more cases of measles, whooping cough and other preventable diseases); ABC News (U.S. measles cases surpass 2,000 for second year in a row); and CIDRAP News (high-dose flu shots cut rates of hospitalization in older adults). Sarah Rohde, MD, Associate Professor of Otolaryngology-Head and Neck Surgery, was quoted in a People magazine story on patient Makalii Andrade, a surfer from Kauai Island who suffered a serious neck injury in 2022 and recently underwent surgery at Vanderbilt Health to begin the final phase of his recovery. James Crowe, MD, Director of the Vanderbilt Center for Antibody Therapeutics, for a piece in Nature about antibodies against a strain of Ebola. SFGATE reporter Gillian Mohney interviewed Xue Zhong, PhD, Research Assistant Professor, Division of Genetic Medicine and Clinical Pharmacology, for a story about a study of a blood test looking at Alzheimer’s disease biomarkers. Matthew Franklin Mart, MD, Assistant Professor of Medicine, was quoted in a Healio story about how inflammation and illness severity is linked to less cognitive resilience after a person has been an ICU patient. The “How We Really Feel” podcast host Sula Windgassen, PhD, interviewed Lindsey C. McKernan, PhD, MPH, Associate Professor of Psychiatry & Behavioral Sciences, Physical Medicine & Rehabilitation and Urology, for an episode focusing on pelvic and bladder health. The podcast is also available on YouTube and the podcast website. In addition, podcaster Monica Sanford interviewed cardiologist Mark Glazer, MD, for her podcast “The Monica Sanford Show”; the two-part interview is here and here.
Why Science Communication Is Breaking Down, and How Philanthropy Can Fix It
A Milken Institute team argues that the biomedical communication pipeline is breaking down at publication, distribution, and public engagement, and that philanthropy is uniquely positioned to repair it.
Powering drug discovery with analytical chemistry
Advances in analytical instrumentation are helping researchers study drug behavior, improve biomedical research, and train the next generation of scientists.
UH researchers awarded $12M grant to advance AI, data science in medicine | University of Hawaiʻi System News
New center will support innovative biomedical research, develop future scientific leaders, and expand research infrastructure in Hawaiʻi.
Western Nevada College students engage in science research, bring education to life
While many college students spend summer break away from campus, a dedicated group of Western Nevada College student researchers devoted a month advancing biomedical science through paid research experiences as […]
Harvard Business School announces 2026-2027 Blavatnik Fellows
Harvard Business School (HBS) has named its 2026-27 Blavatnik Fellows. The fellowship offers HBS alumni and Harvard-affiliated postdoctoral researchers the opportunity to advance new life science technology ventures and develop their leadership talents during a 12-month fellowship year. To date, Blavatnik Fellows have founded 50 biomedical companies developing innovations including gene writing technologies, engineered cell therapies, oral biologic drug delivery platforms, AI-enabled digital health solutions, and therapeutics for cancer, neurological, and metabolic diseases. Collectively, Fellows have raised more than $800 million in private and public capital to advance their ventures.
Nick Coté, pursuing “frugal science” like paper centrifuges and origami microscopes
National Merit Scholar Nick Coté chose Nevada to pursue biomedical engineering and mathematics — and a mission to make science more accessible through paper centrifuges, origami microscopes and creative problem-solving.
Triggering the 'symphonic biology' of exercise for better health
Physician-scientist R. Sanders Williams of Duke University has worked across academia and industry exploring key questions in exercise medicine. The National Academy of Medicine member will deliver the season’s final Maury Strauss Distinguished Public Lecture at the Fralin Biomedical Research Institute at VTC on Thursday, June 4.
Doctors Worry Grant Changes Will Derail Biomedical Science
Proposed OMB grant review changes could shift science funding from peer-reviewed to subject to political whims, impacting drug development and patient care.
University of Hawaiʻi researchers awarded $12M grant to advance AI, data science in medicine
The funding will be dedicated to accelerating biomedical discoveries through AI and data science to benefit people in Hawaiʻi and the Pacific region, and worldwide.
Anthropic's Claude Science could disrupt Kendall Square and biopharma
Few places on the planet have more at stake in AI’s transformation and disruption of life sciences than the Massachusetts biomedical ecosystem.
At Family Science Night, Wonder Comes Before Answers.
BAR HARBOR—Family Science Night isn’t really about science. It’s about wonder. It’s about watching a five-year-old realize that the tiny creature under a microscope is a real living thing. It’s about a teenager discovering that the scientist explaining genetics or regeneration isn’t much older than they are. It’s about parents seeing curiosity spread across a child’s face the way excitement spreads across a crowd at a Fourth of July parade. For one evening, families realize that the laboratory isn’t some secretive place where knowledge is hidden behind white coats and closed doors. They learn that the lab is a place their neighbors work, their friends’ parents work, and it becomes a place where questions matter more than answers. It’s a place where wonder is the origin for knowledge. At the lab, children learn that it’s okay not to know. Adults remember that they once asked “Why?” about everything. Scientists are reminded why they fell in love with discovery in the first place. There are experiments, games, obstacle courses, and demonstrations, of course. But those are really just invitations—to touch, to explore, to laugh, to make mistakes, and to ask one more question. In a world that often rewards certainty, Family Science Night celebrates curiosity. And perhaps that’s its greatest gift. Long after the microscopes are packed away and the experiments are over, what families take home isn’t just a few new facts about biology. They take home the feeling that discovery belongs to everyone—that science isn’t something happening somewhere else by someone else. It’s simply what happens when people are given permission to wonder. A Family Science Night at the Mount Desert Island Biological Laboratory is one of those rare community events where children and adults can experience science as something they do, not just something they read about. Hands on discovery allows hands-on learning and joy. Real scientists, some local, some scientist-interns (but still scientists) just in college make science real, approachable, and exciting. And there, complex ideas like forever chemical-filtration, DNA and so much more become not complex. Instead, they become fun. Summer fellows are challenged to explain cutting-edge biomedical research in ways a first-grader—and their grandparent—can understand. Past activities have explored gene expression, kidney function, axolotl regeneration, worms, microplastics, and phytoplankton through games and creative demonstrations. Though it’s called family night, you can also see adults going from station to station, exploring, learning together across ages. Family Science Night reflects the laboratory’s broader mission of breaking down barriers between researchers and the public, helping people understand how scientific discoveries relate to everyday life and the health of Maine’s environment. Family Science Night transforms a world-class research laboratory into a giant interactive classroom, where curiosity is encouraged, questions are celebrated, and families discover that science isn’t just something that happens in a lab—it’s an adventure anyone can join. About MDI Biological Laboratory For more than 125 years, MDI Bio Lab has been a center for training and research in comparative biology. In the last two decades its biomedical research has focused on aging, regeneration, and environmental toxins. The Laboratory houses 11 research groups staffed by an international team of world-class scientists and graduate students. It also leads a statewide network of colleges, universities and research institutions that collaborate to provide training, research experiences and financial support to help young Mainers play a bigger role in today’s biomedical revolution. Located on Maine’s rugged coast, the Laboratory’s 100+ acre campus houses research facilities, cottages and dorms that house visiting scientists and students. It is also home to MDI Bioscience, a subsidiary working to design innovative techniques to speed the drug discovery process. LINKS TO LEARN MORE NIH INBRE MDI BIOLOGICAL LABORATORY Photos: Carrie Jones and Shaun Farrar/Bar Harbor Story HELP SUPPORT THE BAR HARBOR STORY When we started The Bar Harbor Story, we didn’t know if anyone would read it. But you showed up. You shared. You sent tips. Now—over 400,000 views every month later—it’s clear: people here care about their community and each other. We’ve kept everything free because news should never be out of reach, but every one of our stories takes time to write, and your support keeps The Bar Harbor Story going. If you value our work, please consider a paid subscription, a founding membership, or a sponsorship. It truly helps us cover one more meeting, tell one more story, shine one more light. Even $5 a month makes a difference. Click here to become a one-time supporter now. Thank you so much for being here. Founding member information can be found here. Have questions about sponsorships? Just send Shaun an email at sfarrar86@gmail.com, he’d love to hear from you. Subscribe Share Bar Harbor Story Share Leave a comment
Beacon of discovery
Biomedical science Ph.D. student Lucy Williamson conducts cancer cell research in a Whitley H35 Hypoxystation, which creates hypoxic conditions within a controlled and sustained workstation environment in the Mugar Life Sciences building.
NASA to Study Human Health, Performance During Crew-13 Mission
During NASA's SpaceX Crew‑13 mission aboard the International Space Station, astronauts will support a series of biomedical and human health performance...
These 36 Scientists Are Leading the Way to Biomedical Discoveries
On June 16, Pew announced the 2026 class of Pew Scholars Program in the Biomedical Sciences, Pew Latin American Fellows Program in the Biomedical Sciences, and Pew-Stewart Scholars Program for Cancer Research. These researchers will receive multiyear grants and join a community of more than 1,000 scientists who are taking creative approaches to cancer biology, neuroscience, immunology, and more.
U-M BME Expands Pre-health Advising for Engineering Students Pursuing Careers in Medicine, Health Care
A new advising pilot housed in Biomedical Engineering is helping U-M engineering students and alumni navigate medical, dental, PA, PT, optometry, veterinary and other health professional pathways with more structure, coaching and support.
Two Indian American scientists receive NIH innovative research awards
Neeraj Lal and Kavita Rangan among 42 recipients of federal support for early-career biomedical research projects.
UMass Chan receives Massachusetts Life Sciences Center funding to advance health equity in pregnancy care and biomedical discovery
UMass Chan Medical School researchers have received funding from the Massachusetts Life Sciences Center to advance research using artificial intelligence to improve early identification of pregnancy-induced hypertension and to establish a colorectal cancer biobank that will accelerate biomedical discoveries.
Spacewalk Preps, Biomedical Science as Station Boosts Orbit on Thursday
Preparations are ongoing for a spacewalk next week to continue external maintenance on the International Space Station. The Expedition 75 residents are also keeping up biomedical research while maintaining orbital outpost systems. Also, a U.S. cargo craft fired it engines on Thursday boosting the station’s orbit.
Supporting quantitative skills in biomedical science with smart worksheets: intentions, impact and barriers to engagement
Every year, hundreds of thousands of students arrive at university with one shared weakness: the maths hiding inside their science. In biomedical science, where pipetting volumes, dilution factors, calibration curves and statistical spread underpin nearly every practical
Dragon Nears Launch as Crew Works Biomedical Science and Spacewalk Preps
A SpaceX Falcon 9 rocket, with a cargo-packed Dragon spacecraft atop, stands ready to launch to the International Space Station at 6:05 p.m. EDT today, weather permitting, from Launch Complex 40 at Cape Canaveral Space Force Station in Florida.
What causes sleep paralysis; health indicators of Alzheimer's diagnosis; sober October; plus other stories with Vanderbilt Health sources
(iStock) Food and Wine interviewed Peter Martin, MD, Professor of Psychiatry and Behavioral Sciences, for a story about sober October. William Schaffner, MD, Professor of Preventive Medicine, was quoted in CNN International’s Connect the World with Becky Anderson and NewsNation Morning in America for stories about the reported plague situation in Russia, after a laboratory worker at an institute in Siberia dedicated to studying the plague and other infectious diseases died of a mysterious illness. Prevention interviewed James McGuirk, MD, Assistant Professor, Division of Sleep Medicine, for a story about what causes sleep paralysis. Modern Healthcare interviewed Daniel Fabbri, PhD, Associate Professor of Biomedical Informatics and Computer Science, for a story about how health systems are managing AI token costs. WNKY interviewed Ziv Beckerman, MD, Associate Chief of Pediatric Cardiac Surgery, Surgical Director of Pediatric Heart Transplantation in the Golisano Pediatric Heart Institute at Monroe Carell Jr. Children’s Hospital at Vanderbilt about rapid recovery with extended ultra oxygenated preservation (REUP) that is a new form of preservation for heart organs. Ray Romano, PhD, MPH, MSN, Nurse Practitioner, Vanderbilt Memory & Alzheimer’s Center, was quoted Prevention about research that found other health issues may be an early indicator of Alzheimer’s.
Democratizing discovery through data science
UD's Cathy Wu, elected an AAAS Fellow, advances team science and broadens access to biomedical discovery
Academic Scientists’ Career Confidence Fell Amidst US Policy Changes
A new NBER working paper surveying 916 biomedical PhD students and postdocs found academia-retention intentions fell 22 percentage points in six months.
Israel Pennerman: From The Bahamas to Biomedical Science, A Journey of Discovery & Purpose
Fall 2025 Graduate | Public Health Science For Israel Pennerman, pursuing a degree in Public Health Science was never simply about earning a diploma. It was about gaining the knowledge and skills needed to address health challenges facing communities around the world. Originally from Nassau, The Bahamas, Pennerman arrived at Saint Augustine’s University with a […]
University of Southern Miss to add new science research facility
HATTIESBURG, Miss. (WXXV)- The University of Southern Mississippi plans to add a new state of the art science research facility on the Hattiesburg campus. The Mississippi legislature appropriated $30 million to help make this transformative project possible. This investment will support research and discovery across the biological, biomedical, and environmental sciences while strengthening the university’s position as one of the...
Tahoma High School Biomedical Science and Intro to Acting : VOICE of the Valley
Two very different THS classes — Biomedical Science and Intro to Acting — collaborated last week on a unique, hands-on assignment! Students in this senior-level biomedical class are learning how to triage patients in emergency situations. So, students in the drama class acted as car crash victims — some with injuries, some dead. It was […]
‘Science essential to society’: PhD candidates honored at 2026 award ceremony
Graduating PhD candidates in the Morningside Graduate School of Biomedical Sciences at UMass Chan Medical School were celebrated during an awards ceremony on May 28.